Cancer immunotherapy, mathematical modeling and optimal control

Cites Work

Title not available (Why is that?)
Optimization. Algorithms and consistent approximations
Modeling immunotherapy of the tumor -- immune interaction
Optimal control in a model of dendritic cell transfection cancer immunotherapy
A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
Cancer Modelling and Simulation
Hybrid Necessary Principle
Immunotherapy: an optimal control theory approach
Role of optimal control theory in cancer chemotherapy
Optimal control applied to immunotherapy

Cited In (61)

PDE modeling of bladder cancer treatment using BCG immunotherapy
Controlling IL-7 injections in HIV-infected patients
Equilibria and control of metabolic networks with enhancers and inhibitors
A modified numerical method for bifurcations of fixed points of ODE systems with periodically pulsed inputs
Metaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison
Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control
Improved relaxations for the parametric solutions of ODEs using differential inequalities
Optimal control homotopy perturbation method for cancer model
A mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer
Bacillus Calmette Guerin (BCG) immunotherapy for bladder cancer: a control and mathematical analysis
Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response
Modeling the effect of immunotherapies on human castration-resistant prostate cancer
The combined effects of optimal control in cancer remission
A mathematical model for the dynamics of cancer hepatocytes under therapeutic actions
Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy
A STRATEGY OF OPTIMAL EFFICACY OF T11 TARGET STRUCTURE IN THE TREATMENT OF BRAIN TUMOR
Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine
Effect of awareness programs and travel-blocking operations in the control of HIV/AIDS outbreaks: a multi-domains SIR model
Evolutionary game based control for biological systems with applications in drug delivery
TREATMENT OF BLADDER CANCER USING BCG IMMUNOTHERAPY: PDE MODELING
Determination of the optimal therapeutic protocols in cancer immunotherapy
An optimal control approach to cancer treatment under immunological activity
Mathematical and numerical analysis of a mathematical model of mixed immunotherapy and chemotherapy of cancer
Data-driven optimal control of a SEIR model for COVID-19
Optimal control for predicting customized drug dosage for superovulation stage of \textit{in vitro} fertilization
Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control
Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer
T cell therapy against cancer: a predictive diffuse-interface mathematical model informed by pre-clinical studies
OPTIMAL TREATMENT STRATEGIES USING DENDRITIC CELL VACCINATION FOR A TUMOR MODEL WITH PARAMETER IDENTIFIABILITY
A nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneity
Spatial avascular growth of tumor in a homogeneous environment
Bifurcation analysis of the cancer virotherapy system with time delay and diffusion
A mathematical model of tumour growth with Beddington–DeAngelis functional response: a case of cancer without disease
A time delay model of tumour-immune system interactions: global dynamics, parameter estimation, sensitivity analysis
A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
A mathematical model of cancer treatment by immunotherapy
Optimal CAR T-cell immunotherapy strategies for a leukemia treatment model
Modeling pancreatic cancer dynamics with immunotherapy
Personalized medicine for in vitro fertilization procedure using modeling and optimal control
Bifurcation analysis of a delayed mathematical model for tumor growth
Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy
Modelling pulsed immunotherapy of tumour-immune interaction
Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach
Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach
Cost-effectiveness analysis of optimal strategy for tumor treatment
An agent-based modeling framework linking inflammation and cancer using evolutionary principles: description of a generative hierarchy for the hallmarks of cancer and developing a bridge between mechanism and epidemiological data
Global stability analysis and optimal control therapy of blood cell production process (hematopoiesis) in acute myeloid leukemia
Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer
Investigating of an immune system-cancer mathematical model with Mittag-Leffler kernel
Mathematical models for immunology: current state of the art and future research directions
Fractional order model of immune cells influenced by cancer cells
Practically scheduling hormone therapy for prostate cancer using a mathematical model
Maximization of viability time in a mathematical model of cancer therapy
Bounding the dynamics of a chaotic-cancer mathematical model
Optimal control of acute myeloid leukaemia
Dynamics of fractional-order delay differential model for tumor-immune system
Implementation of fractional optimal control problems in real-world applications
Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent
Numerical solutions and geometric attractors of a fractional model of the cancer-immune based on the Atangana-Baleanu-Caputo derivative and the reproducing kernel scheme
The impact of radio-chemotherapy on tumour cells interaction with optimal control and sensitivity analysis
THE EFFECT OF LENVATINIB AND PEMBROLIZUMAB ON THYROID CANCER REFRACTORY TO IODINE 131I SIMULATED BY MATHEMATICAL MODELING

This page was built for publication: Cancer immunotherapy, mathematical modeling and optimal control

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2219776)